Pharmacoflash / Posters Modérés (PM1) - Méthodologie, pharmacologie clinique
mardi 11 juin 2024
Sessions posters
Sessions de posters modérés
•
S20
•
15h00
>
16h00
•
Pharmacoflash / Posters Modérés (PM1) - Méthodologie, pharmacologie clinique
•
B216
Sessions de posters modérés
Modérateur : Mikaïl NOURREDINE (Lyon)
Posters modérés
•
59
•
PM1-031 - CTCAE classification is insufficient to predict CHeckpoint Inhibitor-induced Liver Injury Severity
>
J-L.
Jean-Luc
Faillie
•
10
•
PM1-032 - Reporting of interventional clinical trial results in a French academic center: a survey of completed studies
>
C.
Clara
Locher
•
84
•
PM1-033 - Association between funding and conclusions of network meta-analyses evaluating targeted therapies in chronic immune-mediated inflammatory diseases : an overview
>
R.
Robin
Guelimi
•
185
•
PM1-034 - Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a systematic review
>
Q.
Quentin
Beytout
•
297
•
PM1-035 - Serious Adverse Events reported to a non-commercial sponsor of clinical trials with the seriousness criterion « important medical event » : are they really serious?
>
M.
Marylaure
Gavard
•
344
•
PM1-036 - Early access authorisation in France: state of the art two years after reforming the authorising procedure for early and derogatory access to medicinal products
>
F.
Fiona
Basset
|